期刊
CLINICAL NUCLEAR MEDICINE
卷 35, 期 2, 页码 128-129出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0b013e3181c7c019
关键词
positron emission tomography; fluorocholine; prostate cancer; sextant; step section histopathology
There is growing experience with F-18 fluorocholine (FCH) for positron emission tomography/computed tomography (PET/CT) imaging of prostate cancer, but limited experience in breast cancer. We report the PET detection of synchronous cancers of the breast and prostate. A 68-year-old man with elevated prostate specific antigen levels underwent PET/CT following injection of 4.7 mCi of FCH with informed consent as part of a clinical research study. PET/CT revealed focal uptake in the left breast that was found by biopsy to be an invasive ductal breast carcinoma. Prostate biopsy also revealed prostate cancer corresponding to an area of increased prostatic FCH uptake. The patient received primary treatments with mastectomy and prostatectomy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据